vigabatrin has been researched along with Brain Swelling in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Affected versus unaffected patients, respectively, had a median age of 11 months versus 5 years, therapy duration 3 months versus 12 months, and dosage 170 mg/kg/day versus 87 mg/kg/day." | 1.35 | Cerebral MRI abnormalities associated with vigabatrin therapy. ( Conry, JA; de Menezes, MS; Elling, NJ; Ferri, R; Gaillard, WD; Gilles, E; Goodkin, HP; Heffron, A; Kadom, N; McCarter, R; McClintock, WM; Molloy-Wells, E; Pearl, PL; Saneto, RP; Trzcinski, S; Vezina, LG, 2009) |
| " In an attempt to image these changes in vivo, we performed high-field MRI on seven treated and four control dogs at baseline and after 15 weeks of dosing with vigabatrin (300 mg/kg/d)." | 1.29 | MRI monitoring of vigabatrin-induced intramyelinic edema in dogs. ( Arezzo, JC; Gibson, JP; Heydorn, WE; Kastin, SJ; McBride, RG; Schroeder, CE; Sussman, NM; Weiss, KL; Yarrington, JT, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pearl, PL | 2 |
| Poduri, A | 1 |
| Prabhu, SP | 1 |
| Harini, C | 1 |
| Goldstein, R | 1 |
| Atkinson, RM | 1 |
| Armstrong, D | 1 |
| Kinney, H | 1 |
| Vezina, LG | 1 |
| Saneto, RP | 1 |
| McCarter, R | 1 |
| Molloy-Wells, E | 1 |
| Heffron, A | 1 |
| Trzcinski, S | 1 |
| McClintock, WM | 1 |
| Conry, JA | 1 |
| Elling, NJ | 1 |
| Goodkin, HP | 1 |
| de Menezes, MS | 1 |
| Ferri, R | 1 |
| Gilles, E | 1 |
| Kadom, N | 1 |
| Gaillard, WD | 1 |
| Cocito, L | 1 |
| Maffini, M | 1 |
| Weiss, KL | 1 |
| Schroeder, CE | 2 |
| Kastin, SJ | 1 |
| Gibson, JP | 3 |
| Yarrington, JT | 2 |
| Heydorn, WE | 3 |
| McBride, RG | 1 |
| Sussman, NM | 3 |
| Arezzo, JC | 2 |
| Peyster, RG | 1 |
| Hershey, BL | 1 |
| Meyerson, LR | 1 |
| Yarrington, J | 1 |
1 review available for vigabatrin and Brain Swelling
| Article | Year |
|---|---|
Vigabatrin.
Topics: 4-Aminobutyrate Transaminase; Aminocaproates; Animals; Anticonvulsants; Brain Edema; Epilepsy; Human | 1989 |
6 other studies available for vigabatrin and Brain Swelling
| Article | Year |
|---|---|
White matter spongiosis with vigabatrin therapy for infantile spasms.
Topics: Anticonvulsants; Brain Edema; Child, Preschool; Fatal Outcome; Humans; Infant, Newborn; Male; Spasms | 2018 |
Cerebral MRI abnormalities associated with vigabatrin therapy.
Topics: Adolescent; Anticonvulsants; Brain; Brain Edema; Child; Child, Preschool; Diffusion Magnetic Resonan | 2009 |
Vigabatrin edema.
Topics: Anticonvulsants; Brain; Brain Edema; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Vi | 1995 |
MRI monitoring of vigabatrin-induced intramyelinic edema in dogs.
Topics: 4-Aminobutyrate Transaminase; Animals; Brain Edema; Dogs; gamma-Aminobutyric Acid; Hippocampus; Hypo | 1994 |
Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain.
Topics: Animals; Anticonvulsants; Brain; Brain Edema; Dogs; Dose-Response Relationship, Drug; Female; gamma- | 1995 |
Effects of high-dose gamma-vinyl GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs.
Topics: Aminocaproates; Animals; Anticonvulsants; Brain Edema; Dogs; Dose-Response Relationship, Drug; Drug | 1992 |